文献速递心脏核医学肿瘤 PET/CT

两种示踪剂的故事——研究性放射性示踪剂碘-124 evuzamitide与锝-99m p5+14(AT-05)的淀粉样蛋白显像

A tale of two tracers - amyloid imaging with investigational radiotracers iodine (124I) evuzamitide and 99mTc-p5+14 (AT-05).
PubMed 文献 · J Nucl Cardiol · 2025-09-05

本文总结并对比了两种基于肽p5+14的淀粉样蛋白显像放射性示踪剂:碘-124标记的evuzamitide用于PET/CT,锝-99m标记的p5+14用于SPECT/CT,二者均可与各型淀粉样蛋白结合,可检测心脏和心外淀粉样蛋白沉积,图像数据相似但各具特点且互补。

要点

  • 肽p5+14通过多价静电相互作用与所有类型淀粉样蛋白结合。
  • 碘-124 evuzamitide已历经八项研究者发起的 study,现处于检测心脏淀粉样变性的关键3期REVEAL研究。
  • 两种示踪剂均可对心脏转甲状腺素蛋白(ATTR)和免疫球蛋白轻链(AL)淀粉样变性显像。

核心结论

  • 碘-124 evuzamitide与锝-99m p5+14两种放射性示踪剂因核素特性不同,图像和图像数据相似但各具特点且互补。

研究设计与样本

  • 本文基于田纳西大学医学中心的经验数据,总结并对比碘-124 evuzamitide与锝-99m p5+14两种淀粉样蛋白显像放射性示踪剂的特性。
  • 碘-124 p5+14(碘-124 evuzamitide)已在八项研究者发起的研究中接受评估,现处于检测心脏淀粉样变性的关键3期REVEAL研究。

主要发现

  • 肽p5+14可通过多价静电相互作用与所有类型的淀粉样蛋白结合。
  • 碘-124标记的p5+14可使用PET/CT检测心脏和心外淀粉样蛋白沉积,锝-99m标记的p5+14可使用SPECT/CT检测心脏和心外淀粉样蛋白沉积。
  • 两种放射性示踪剂均可对心脏转甲状腺素蛋白(ATTR)和免疫球蛋白轻链(AL)淀粉样变性显像。
  • 系统性淀粉样变性最常见的类型与错误折叠的转甲状腺素蛋白或免疫球蛋白轻链相关,其中心脏和肾脏淀粉样变性预后最差。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Systemic amyloidosis is a complex disorder, making early and accurate diagnosis challenging. The most common types are associated with misfolded transthyretin or immunoglobulin light chains, where cardiac and renal amyloidosis portend the worst prognosis. Peptide p5+14 can bind all types of amyloid via multivalent electrostatic interactions. When radiolabeled with either iodine-124 or technetium-99m, it can be used to detect cardiac and extracardiac amyloid deposits using positron emission tomography/computed tomography (PET/CT) or single-photon emission computed tomography/CT (SPECT/CT) imaging, respectively. 124I-p5+14 (124I-evuzamitide) has been evaluated in eight investigator-initiated studies and is now in a pivotal Phase 3 study (REVEAL) for the detection of cardiac amyloidosis. Both radiotracers image cardiac transthyretin (ATTR) and immunoglobulin light chain (AL) amyloidosis; however, due to the characteristics of the radionuclides, the images and image data are similar but uniquely different and complementary. Using data collected from the University of Tennessee Medical Center experiences, herein, we summarize and contrast characteristics of 124I-evuzamitide and 99mTc-p5+14 as radiotracers for amyloid detection.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Martin EB, Kassira A, Stuckey A, et al. A tale of two tracers - amyloid imaging with investigational radiotracers iodine (124I) evuzamitide and 99mTc-p5+14 (AT-05). J Nucl Cardiol. 2025. PMID: 40914639. doi:10.1016/j.nuclcard.2025.102451

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。